Dr Sonya Abraham

Printer-friendly version

Dr Sonya AbrahamDr. Abraham is a Clinical Senior Lecturer in Rheumatology and General Internal Medicine. She undertook her medical training in London, Oxford and Cambridge. She was a Clinical Lecturer at the Kennedy Institute of Rheumatology and undertook her PhD, as a Wellcome Clinical Training Fellow, examining the effect of glucocorticoids on pro-inflammatory intracellular signalling. Her novel finding was that a Dual Specificity Phosphatase (DUSP1) renders partial glucocorticoid resistance (J Exp Med 2006). Basic Science interests include intracellular signalling regulation, post-transcriptional regulation and RNA stability.

She is lead for clinical trials in inflammatory arthritis and north-west London LCRN musculoskeletal lead and Division 5 lead.  Nationally, she is the CCRN musculoskeletal industry liaison lead. She is also represents Imperial College on the Translational Partnerships for arthritis and inflammatory diseases.

Additionally, she is engaged in a number of Public and Patient engagement initiatives to help  understanding the needs and value of  biomedical research.

With her interest in translational and experimental medicine, she is developing a biomarker/imaging and drug discovery programme in Psoriatic arthritis (Psa) and Psoriasis (Pso).